Reduction in Risk Across Fourteen Obesity-Related Cancers A large observational study presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025, involving more than 170,000 patients with diabetes and obesity, found that GLP-1 receptor agonists were associated with a modest but statistically meaningful reduction in the incidence of 14 obesity-related cancers , with colorectal cancer demonstrating particularly favourable outcomes when compared to patients receiving DPP-4 inhibitors
But a whole new arenadaily weight-loss pillsis changing the rules of the game once again
It is a prescription-only medication for type 2 diabetes and weight management (off-label)
REPORTER 2: You're on Ozempic or one of those things
During the first week, you might notice what is commonly referred to as a reduction in food noise. This means you may spend less time obsessing over your next meal or craving certain snacks
This kind of personalized care is what makes our program so effective, ensuring that every patient receives the support and guidance they need to succeed